Leonard A. Farber
Chief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory BoardDr. Leonard A. Farber, M.D., is Chief Clinical & Medical Affairs Officer of Nanobiotix S.A. from February 2022 and serves as its Chairman of the Scientific Advisory Board. Dr. Farber is Section Chief of Radiation Oncology and Senior Medical Director of Care To Care, LLC. Dr. Farber is Principal of Healthcare & Life Sciences of Vivaris Capital, LLC from 2022. Dr. Farber was Member of Scientific Advisory Board of Adgero Biopharmaceuticals Holdings, Inc. Dr. Farber joined the Adgero Biopharmaceuticals Holdings, Inc. on April 14, 2016. Dr. Farber was Member of Scientific Advisory Board of Adgero Biopharmaceuticals Holdings, Inc. Dr. Farber has B.A. from State University of New York at Binghamton, B.S. from State University of New York at Binghamton, M.D. from Icahn School of Medicine at Mount Sinai.
Positions
- Company NameNanobiotix S.A.Stock CodeNBTXPositionChief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory BoardColleagues
- LLLaurent LevyCo-Founder, President of the Executive Board & CEO
- GMGary M. PhillipsIndependent Chairman of Supervisory board
- AHAnne-Juliette HermantChief People Officer & Member of Executive Board
- LKLouis KayitalireChief Medical Officer & Member of Executive Board
- EJEarl J. BergeyCo-Founder
- ACArnd ChristCFO & Member of Executive Board
- AGAnne-Marie GraffinIndependent Vice Chairwoman of the Supervisory Board
- ESEnno SpillnerIndependent Member of Supervisory Board
- AHAlain HerreraIndependent Member of Supervisory Board
